Clinical Trial Update: Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the efficacy and safety of naldemedine for opioid-induced constipation. The trial was conducted by Shionogi and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• Naldemedine (naldemedine)

Snippet

Sponsor: Shionogi | Conditions: Opioid-induced Constipation | Phase 3 | Status: COMPLETED | Results posted: 2017-05-30